Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05190445
Title Cinrebafusp Alfa in Combination With Ramucirumab and Paclitaxel in HER2-High Gastric or GEJ Adenocarcinoma and in Combination With Tucatinib in HER2-Low Gastric or GEJ Andenocarinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pieris Pharmaceuticals, Inc.
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Sansum Clinic Santa Barbara California 93105 United States Details
Maryland Oncology-Hematology Silver Spring Maryland 20904 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Samsung Medical Center Seoul Korea, Republic of Details
*Shaded cells indicate that there was no data available from for the field